Levodopa in the treatment of Parkinson's disease: A consensus meeting

Movement Disorders

Volumn 14, Issue 6, 1999, Pages 911-913

  Agid, Y ^a   Ahlskog, E ^b   Albanese, A ^b   Calne, D ^b   Chase, T ^b   De Yebenes, J ^b   Factor, S ^b   Fahn, S ^b   Gershanik, O ^b   Goetz, C ^b   Koller, W ^b   Kurth, M ^b   Lang, A ^b   Lees, A ^b   Lewitt, P ^b   Marsden, D ^b   Melamed, E ^b   Michel, P P ^b   Mizuno, Y ^b   Obeso, J ^b   Oertel, W ^b   Olanow, W ^b   Poewe, W ^b   Pollak, P ^b   Przedzorski, S ^b   Quinn, N ^b   Raisman Vozari, R ^b   Rajput, A ^b   Stocchi, F ^b   Tolosa, E ^b   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPA DECARBOXYLASE INHIBITOR; LEVODOPA;

CELL DEATH; DRUG EFFICACY; DRUG TOLERANCE; DYSKINESIA; GLIA CELL; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; MOTOR DYSFUNCTION; NERVE DEGENERATION; NONHUMAN; NOTE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; BRAIN; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 0032730204     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199911)14:6<911::AID-MDS1001>3.0.CO;2-H     Document Type: Note

References (1)

1. Murer MG, Dziewczapolski G, Menalled LB, et al. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Ann Neurol 1998;43:561-575.